“BioNTech/Pfizer/(BNT162b2)/COVID-19/MRNA/Vaccine:/Manufacturing,/Immunogenicity,/Efficacy/and/Safety”. Prospects in Pharmaceutical Sciences, vol. 23, no. 1, Feb. 2025, pp. 31-46, https://doi.org/10.56782/pps.292.